Nyrada (ASX:NYR) - CEO, James Bonnar
CEO, James Bonnar
Source: Perth Now
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Nyrada (NYR) receives a $1.3 million research and development rebate
  • The rebate relates to expenditure on cholesterol-lowering and brain injury drug development programs
  • The amount received will partially fund the progression of two Phase I clinical trials, as well as the working capital requirements of Nyrada
  • Shares in Nyrada were up 4 per cent and last traded at 26 cents each

Drug discovery and development company Nyrada (NYR) has received a $1.3 million cash rebate from the Australian Federal Government’s Research & Development tax incentive program.

The rebate relates to expenditure incurred in the 2021 financial year, specifically preclinical work for the company’s two main projects.

The company says the projects target markets of significant size and considerable unmet clinical needs.

One project is a cholesterol-lowering drug development program.

The other is developing a drug to treat brain injury, specifically traumatic brain injury and stroke.

The amount received will partially fund the progression of these two Phase I clinical trials, as well as the working capital requirements of Nyrada.

Shares in Nyrada were up 4 per cent and last traded at 26 cents each as of 4:06 pm AEDT.

NYR by the numbers
More From The Market Online
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…